|
| n | C肽 | FINS/FBG | HbA1c(%) | TC(mmol/L) | TG(mmol/L) | HDL-C | TC/ HDL-C |
观察组 | 治疗前 | 152 | 1.06 ± 0.54 | 3.02 ± 1.08 | 6.64 ± 0.48 | 5.88 ± 1.35 | 5.41 ± 1.73 | 0.98 ± 0.26 | 6.60 ± 2.68 |
治疗后 | 0.89 ± 0.55 | 2.50 ± 1.22* | 6.45 ± 0.50 | 5.40 ± 1. 02 | 4.64 ± 1.07* | 1.03 ± 0.21 | 5.48 ± 1.45* | ||
对照组 | 治疗前 | 152 | 1.06 ± 0.61 | 2.42 ± 1.38 | 6.66 ± 0.49 | 5.95 ± 1.33 | 5.77 ± 1.52 | 0.99 ± 0.246 | 5.52 ± 2.46 |
治疗后 | 0.94 ± 0.58 | 2.35 ± 1.73 | 6.43 ± 0.51 | 5.47 ± 0. 93 | 5.07 ± 0.76* | 1.05 ± 0.21 | 5.38 ± 1.13* |